A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches
Public ClinicalTrials.gov record NCT00781456. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy of DR-105 Compared to Placebo For the Management of Menstrually-Related Migraine Headaches.
Study identification
- NCT ID
- NCT00781456
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Duramed Research
- Industry
- Enrollment
- 109 participants
Conditions and interventions
Conditions
Interventions
- 91-day Levonorgestrel Oral Contraceptive Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 34 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2008
- Primary completion
- Jul 31, 2011
- Completion
- Jul 31, 2011
- Last update posted
- Feb 5, 2017
2009 – 2011
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site | La Mesa | California | 91942 | — |
| Duramed Investigational Site | San Diego | California | 92108 | — |
| Teva Investigational Site | San Diego | California | 92123 | — |
| Duramed Investigational Site | San Francisco | California | 94109-4841 | — |
| Duramed Investigational Site | Washington D.C. | District of Columbia | 20036 | — |
| Duramed Investigational Site | West Palm Beach | Florida | 33409 | — |
| Teva Investigational Site | Savannah | Georgia | 31406 | — |
| Duramed Investigational Site | Edison | New Jersey | 08817 | — |
| Duramed Investigational Site | New York | New York | 10022 | — |
| Teva Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Teva Investigational Site | Tulsa | Oklahoma | 74105 | — |
| Teva Investigational Site | Medford | Oregon | 97504 | — |
| Duramed Investigational Site | Philadelphia | Pennsylvania | 19114 | — |
| Teva Investigational Site | Uniontown | Pennsylvania | 15401 | — |
| Teva Investigational Site | Columbia | South Carolina | 29201 | — |
| Teva Investigational Site | Hilton Head | South Carolina | 29926 | — |
| Teva Investigational Site | Memphis | Tennessee | 38120 | — |
| Duramed Investigational Site | Dallas | Texas | 75234 | — |
| Teva Investigational Site | Houston | Texas | 77054 | — |
| Duramed Investigational Site | San Antonio | Texas | 78258 | — |
| Duramed Investigational Site | Virginia Beach | Virginia | 23454 | — |
| Duramed Investigational Site | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00781456, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 5, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00781456 live on ClinicalTrials.gov.